- Home
- Software Solutions
- Resources
- Corporate
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Clinical Studies by Phase of Development
Active Clinical Trials 
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Active | Respiratory Syncytial Virus Infections | >ALN-RSV01 >Normal Saline | Phase_II | Phase 2b Study of ALN-RSV... | NCT01065935 |
| Active | Solid Tumors | >ALN-VSP02 | Phase_I | Dose Escalation Trial to ... | NCT00882180 |
| Active | Transthyretin Mediated Amyloidosis (ATTR) | >ALN-TTR01 >Sterile Normal Saline (0.9% NaCl) | Phase_I | Trial to Evaluate Safety ... | NCT01148953 |
| Active | Solid Tumors | >ALN-VSP02 | Phase_I | Multi-center, Open Label,... | NCT01158079 |
| Active | Elevated LDL-Cholesterol (LDL-C) | >ALN-PCS02 >Sterile Normal Saline (0.9% NaCl) | Phase_I | Trial to Evaluate Safety ... | NCT01437059 |
Completed Clinical Trials
| Status | Indication | Name(s) | Phase | Trial Name | Identification |
|---|---|---|---|---|---|
| Completed | Respiratory Syncytial Virus Infections | >ALN-RSV01 | Phase_II | Intranasal ALN-RSV01 Admi... | NCT00496821 |
| Completed | Respiratory Syncytial Virus Infections | >ALN-RSV01 >normal saline | Phase_II | Phase 2 Study of ALN-RSV0... | NCT00658086 |